Gregory W. Albers

550 papers receiving 39.8k citations

Gregory W. Albers's Hit Papers

Collateral Effect of Covid-19 on Stroke Evaluation in the United States 2020 · 296 citations
2960+8+16Years since publication50010001.5k

Peers

Gregory W. Albers
Comparison fields: 5 of 178
  • Internal Medicine 4.3k
  • Epidemiology 22.3k
  • Neurology 7.7k
  • Rehabilitation 3.2k
  • Pulmonary and Respiratory Medicine 10.7k
Replace Lee H. Schwamm with:
Lee H. Schwamm United States
Werner Hacke Germany
Harold P. Adams United States
Michael D. Hill Canada
Markku Kaste Finland
Geoffrey A. Donnan Australia
Chelsea S. Kidwell United States
José Biller United States
Karen L. Furie United States
Joseph P. Broderick United States
Gregory W. Albers relative to Lee H. Schwamm United States Lee H. Schwamm's profile →
Citations per field
00.5×1.6×
Lee H. Schwamm · 1×
Citations per year

Countries citing papers authored by Gregory W. Albers

Since Specialization
Citations

This map shows the geographic impact of Gregory W. Albers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory W. Albers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory W. Albers more than expected).

Fields of papers citing papers by Gregory W. Albers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory W. Albers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory W. Albers. The network helps show where Gregory W. Albers may publish in the future.

Co-authors

The 25 scholars most cited alongside Gregory W. Albers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gregory W. Albers Line = papers co-authored together Gregory W. Albers links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 586 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
Hit paper breakdown →
20101633
2
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
Hit paper breakdown →
20061430
3
Definition and Evaluation of Transient Ischemic Attack
Hit paper breakdown →
20091304
4
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
Hit paper breakdown →
20101159
5
Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study
Hit paper breakdown →
2006972
6
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset
Hit paper breakdown →
1999913
7
Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial
Hit paper breakdown →
2012849
8
A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke
Hit paper breakdown →
2001823
9
The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)
Hit paper breakdown →
2004819
10
Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
Hit paper breakdown →
2012684
11
Transient Ischemic Attack — Proposal for a New Definition
Hit paper breakdown →
2002604
12
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study
Hit paper breakdown →
2012597
13
Antithrombotic Therapy in Atrial Fibrillation
Hit paper breakdown →
2008581
14
Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
Hit paper breakdown →
2000572
15
Ximelagatran vs Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation
Hit paper breakdown →
2005524
16
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Hit paper breakdown →
1998512
17 2004441
18 2006434
19 1997426
20 2006425

About Gregory W. Albers

Gregory W. Albers is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine, Neurology, Internal Medicine and Radiology, Nuclear Medicine and Imaging, having authored 586 papers that have together received 41.9k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (378 papers), Cerebrovascular and Carotid Artery Diseases (127 papers), Venous Thromboembolism Diagnosis and Management (69 papers), Traumatic Brain Injury and Neurovascular Disturbances (39 papers), Atrial Fibrillation Management and Outcomes (36 papers), Advanced MRI Techniques and Applications (32 papers), Antiplatelet Therapy and Cardiovascular Diseases (28 papers) and MRI in cancer diagnosis (20 papers). The work is most often cited by research in Internal Medicine (4.3k citations), Epidemiology (22.3k citations), Neurology (7.7k citations), Rehabilitation (3.2k citations) and Pulmonary and Respiratory Medicine (10.7k citations). Gregory W. Albers has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Maarten G. Lansberg, Michael P. Marks, Scott Hamilton, Michael E. Moseley, Michael Mlynash, Ralph L. Sacco, J. Donald Easton, Roland Bammer, Stephanie Kemp and Vincent Thijs. Their work appears in journals such as Stroke, Neurology, International Journal of Stroke, Journal of Stroke and Cerebrovascular Diseases and Journal of NeuroInterventional Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact